GDF15 and graft versus host disease: Moreover, both GDF-15 and suPAR concentrations were associated with EASIX at day 100 and the last follow-up, and these findings are comparable with our previous study where EASIX at the same time points was significantly higher in HSCT-TMA and GVHD compared with controls [63].